Glebionis coronaria
Glebionis coronaria · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Glebionis coronaria is a botanical species that has gained scientific interest due to its diverse pharmacological activities. Recent studies focusing on methanolic extracts of its seeds have revealed significant therapeutic potential. These extracts demonstrate important properties, acting as an acidulant, an analgesic, and an aldose-reductase inhibitor. Furthermore, the plant has been investigated for its role in addressing conditions related to SARS-CoV-2. However, users should remain cautious as the plant is also known to be allergenic.
- Synonyms
- Chrysanthemum Coronarium Alboflavum · Pyrethrum Indicum · 18 more
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Seed
Classification
Common Names
Glebionis coronaria is a distinctive plant known by several diverse names across different languages and cultures. In its native Dutch context, it is commonly referred to as the Gekroonde ganzenbloem. This botanical species also carries the name Kronen-Wucherblume in German, reflecting its unique growth patterns. English speakers frequently identify it as the Crown Daisy, a name that highlights its ornamental beauty. Furthermore, it is widely recognized in Spanish-speaking regions as Pajito.
Sources: Catalogue of Life (COL)
Synonyms
Glebionis coronaria is a plant species characterized by a complex history of botanical nomenclature. Over time, several scientific names have been applied to this taxon, including the synonym Buphthalmum oleraceum. It has also been historically classified under various Chrysanthemum labels, such as Chrysanthemum coronarium and Chrysanthemum breviradiatum. Furthermore, the names Chamaemelum coronarium and Chrysanthemum coronarium alboflavum are recognized as synonymous with the species. Navigating these diverse botanical relationships is essential for accurate identification and scientific study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Glebionis coronaria is a distinctive species belonging to the vast kingdom Plantae. Within this biological realm, it is classified under the class Equisetopsida. The plant is a member of the order Asterales, which connects it to a diverse group of flowering plants. Furthermore, it falls under the family Asteraceae, a group well-known for its complex flower heads. Finally, its specific taxonomic identity is defined by its placement within the genus Glebionis.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Glebionis |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Glebionis coronaria maintains a broad and diverse geographical presence across several continents and island groups. Its range extends significantly throughout Africa, with specific occurrences noted in Northeast Tropical Africa and Eritrea. The species is also well-established within the Macaronesia region, flourishing across various archipelagos. This includes widespread distribution in the Azores, the Canary Islands, and Madeira. Additionally, its reach encompasses the Selvagens, highlighting its ability to thrive in these unique Atlantic habitats.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Glebionis coronaria is a distinctive herb characterized by its sturdy, self-supporting structure. This plant exhibits significant versatility in its physical dimensions depending on its growing conditions. While it can remain quite small at a minimum height of 0.15 m, it frequently reaches a more substantial stature of 0.7 m. In optimal environments, the growth can extend even further to reach a maximum height of 1.5 m. Such varied development highlights the adaptable nature of this resilient species.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Glebionis coronaria, also known as Chrysanthemum coronarium, demonstrates significant biological properties that make it a subject of intense scientific interest. Research has identified a novel protein called chrysancorin within its seeds that possesses potent antifungal activity against specific pathogens like Botrytis cinerea. Furthermore, methanolic extracts of the plant have been evaluated for their broader medicinal potential in traditional treatments. These studies confirm that the plant exhibits antimicrobial activity against opportunistic microorganisms such as Staphylococcus aureus and Candida albicans. Ultimately, these findings suggest that the plant may play a valuable role in managing infections and reducing inflammation.
Compounds
Conditions
Glebionis coronaria, also known as Chrysanthemum coronarium, possesses significant therapeutic potential against various pathogens. Specifically, the protein chrysancorin isolated from its seeds demonstrates effective antifungal activity against Botrytis cinerea, Mycosphaerella arachidicola, and Physalospora piricola. Beyond fungal management, research indicates that this plant contains compounds that may play a role in the mitigation of SARS-CoV-2. Furthermore, methanolic extracts of the plant have shown demonstrated antimicrobial and anti-inflammatory activities. These properties support its traditional use in treating a variety of bacterial and fungal infections.
Preparations
Glebionis coronaria, also referred to in the study as Chrysanthemum coronarium, is prepared as methanolic extracts for medicinal evaluation. These specific extracts are utilized to investigate antimicrobial and anti-inflammatory potential against opportunistic microorganisms. By employing a methanolic preparation, researchers can test the plant's ability to inhibit pathogens such as Staphylococcus aureus and Candida albicans. The study specifically focuses on how these methanolic extracts interact with pro-inflammatory cytokines like IL-6. Ultimately, the preparation of Glebionis coronaria as a methanolic extract allows for the assessment of its therapeutic efficacy in reducing inflammation and microbial growth.
Parts used
Glebionis coronaria, commonly known as the garland chrysanthemum, contains specialized seeds that serve as a vital source for biochemical research. Scientists have successfully isolated a novel antifungal protein named chrysancorin from these specific seeds. This protein is particularly notable for its ability to stimulate the proliferation of mouse splenocytes. Additionally, chrysancorin demonstrates significant inhibitory effects against the human immunodeficiency virus-1 reverse transcriptase. Beyond its immunological properties, the protein provides targeted antifungal activity against several specific plant pathogens.